• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.18% Nasdaq Up 0.09%

    Grifols, S.A. (GRFS)

    -NasdaqGS
    34.81 Up 0.89(2.62%) 12:51PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:33.92
    Open:34.05
    Bid:34.83 x 200
    Ask:34.87 x 500
    1y Target Est:38.73
    Beta:1.25
    Next Earnings Date:N/A
    Day's Range:33.99 - 34.93
    52wk Range:29.24 - 46.66
    Volume:408,509
    Avg Vol (3m):501,795
    Market Cap:23.82B
    P/E (ttm):50.78
    EPS (ttm):0.69
    Div & Yield:0.49 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GRFSUp 2.62%23.82B
    HEMA 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):15.77
    P/S (ttm):6.53
    Ex-Dividend Date:04-Dec-14

    Analysts

    Annual EPS Est (Dec-14) :2.09
    Quarterly EPS Est (Dec-14) :0.57
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, Canada, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback